BANK OF AMERICA CORP /DE/ - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$142,000
-38.0%
29,289
+36.1%
0.00%
Q4 2019$229,000
-21.6%
21,515
-23.2%
0.00%
Q3 2019$292,000
-73.0%
28,029
-60.4%
0.00%
Q2 2019$1,083,000
-44.0%
70,695
-53.1%
0.00%
Q1 2019$1,935,000
+1815.8%
150,577
+1311.4%
0.00%
Q4 2018$101,000
-9.8%
10,669
+56.8%
0.00%
Q3 2018$112,000
-66.0%
6,803
-66.9%
0.00%
Q2 2018$329,000
+108.2%
20,548
+97.8%
0.00%
Q1 2018$158,000
+53.4%
10,389
+56.0%
0.00%
Q4 2017$103,000
+119.1%
6,659
+55.7%
0.00%
Q3 2017$47,000
+56.7%
4,276
+32.1%
0.00%
Q2 2017$30,000
-41.2%
3,237
-45.6%
0.00%
Q1 2017$51,000
+4.1%
5,946
+30.8%
0.00%
Q4 2016$49,000
+48.5%
4,547
+53.7%
0.00%
Q3 2016$33,000
+83.3%
2,959
+14.8%
0.00%
Q2 2016$18,000
-83.2%
2,577
-88.8%
0.00%
Q1 2016$107,000
-22.5%
23,065
+5.2%
0.00%
Q4 2015$138,000
+626.3%
21,916
+925.5%
0.00%
Q3 2015$19,000
-20.8%
2,137
+4.9%
0.00%
Q2 2015$24,0000.0%2,037
+22.0%
0.00%
Q1 2015$24,000
-51.0%
1,670
-42.3%
0.00%
Q4 2014$49,000
+1533.3%
2,894
+891.1%
0.00%
Q3 2014$3,000
-98.1%
292
-97.2%
0.00%
Q2 2014$154,00010,500
+52400.0%
0.00%
Q1 2014$0
-100.0%
20
-99.7%
0.00%
Q4 2013$126,000
+260.0%
6,429
+740.4%
0.00%
Q3 2013$35,000
-87.7%
765
-93.6%
0.00%
Q2 2013$285,00011,9490.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders